A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the critical federal funding at risk and what this ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the ...

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolic ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA ...

Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...

Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone in the company’s transition ...